Experience in the management of erectile dysfunction using the intracavernosal self-injection of vasoactive drugs.
We report the results of a survey of 75 patients with erectile dysfunction, all of whom were treated by self-injection of the corpora cavernosa with vasoactive agents. At the time of the survey each patient had been self-injecting at home for at least 3 months. Of the patients 62 were followed for 3 to 21 months. Patients used this form of treatment with minimal assistance from our clinic staff. It was acceptable to them with few complications except for prolonged erections in 11 per cent of the men. Fifteen patients (24 per cent) with psychogenic impotence reported spontaneous improvement in erections during treatment and 4 discontinued treatment for this reason. Another 26 patients (42 per cent) continue to use self-injection as the definitive mode of treatment for erectile dysfunction.
Watters
G R
GR
Reproductive Medicine Research Institute, Nedlands, Western Australia.
Keogh
E J
EJ
Earle
C M
CM
Carati
C J
CJ
Wisniewski
Z S
ZS
Tulloch
A G
AG
Lord
D J
DJ
D000328:Adult; D000368:Aged; D004359:Drug Therapy, Combination; D007172:Erectile Dysfunction / Q000188:drug therapy* / Q000523:psychology; D005500:Follow-Up Studies; D006801:Humans; D007267:Injections / Q000379:methods; D008297:Male; D008875:Middle Aged; D010208:Papaverine / Q000008:administration & dosage*; D010342:Patient Acceptance of Health Care; D010353:Patient Education as Topic; D010413:Penis; D010646:Phentolamine / Q000008:administration & dosage*; D012646:Self Administration
D010208:Papaverine; D010646:Phentolamine